We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTGC icon
2501
Hercules Capital
HTGC
$3.17B
$529K ﹤0.01%
29,286
-177,179
-86% -$3.11M
SEAT icon
2502
Vivid Seats
SEAT
$81.2M
$528K ﹤0.01%
2,388
-1,316
-36% -$280K
BCE icon
2503
BCE
BCE
$21.7B
$527K ﹤0.01%
+9,504
New +$504K
AFAQ
2504
DELISTED
AF Acquisition Corp
AFAQ
$526K ﹤0.01%
+53,868
New +$523K
KBAL
2505
DELISTED
Kimball International
KBAL
$525K ﹤0.01%
62,128
+49,017
+374% +$466K
APLS
2506
DELISTED
Apellis Pharmaceuticals
APLS
$524K ﹤0.01%
10,304
-15,993
-61% -$706K
CRGY icon
2507
Crescent Energy
CRGY
$3.95B
$523K ﹤0.01%
30,143
+3,085
+11% +$45.6K
IRMD icon
2508
iRadimed
IRMD
$1.11B
$523K ﹤0.01%
11,668
+6,386
+121% +$295K
AMSF icon
2509
AMERISAFE
AMSF
$504M
$522K ﹤0.01%
10,516
-9,064
-46% -$463K
LADR
2510
Ladder Capital
LADR
$1.27B
$522K ﹤0.01%
43,961
+33,965
+340% +$399K
DEVS
2511
DELISTED
DevvStream Corp
DEVS
$522K ﹤0.01%
+5,260
New +$520K
VZIO
2512
DELISTED
VIZIO Holding Corp.
VZIO
$522K ﹤0.01%
58,708
+45,253
+336% +$603K
CPS icon
2513
Cooper-Standard Automotive
CPS
$484M
$521K ﹤0.01%
+59,372
New +$971K
HIPO icon
2514
Hippo Holdings
HIPO
$869M
$521K ﹤0.01%
10,468
-394
-4% -$20.4K
DNLI icon
2515
Denali Therapeutics
DNLI
$3.97B
$520K ﹤0.01%
16,169
+8,303
+106% +$286K
SJR
2516
DELISTED
Shaw Communications Inc.
SJR
$519K ﹤0.01%
16,708
-12,379
-43% -$372K
RLAY icon
2517
Relay Therapeutics
RLAY
$4.37B
$518K ﹤0.01%
17,298
+9,653
+126% +$234K
USAK
2518
DELISTED
USA Truck Inc
USAK
$518K ﹤0.01%
+25,141
New +$551K
VTOL icon
2519
Bristow Group
VTOL
$1.38B
$517K ﹤0.01%
13,949
+7,051
+102% +$241K
THACU
2520
DELISTED
Thrive Acquisition Corporation Unit
THACU
$516K ﹤0.01%
51,097
+189
+0.4% +$1.91K
OMIC
2521
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$513K ﹤0.01%
2,709
+2,159
+393% +$500K
SKIN icon
2522
SkinHealth Systems
SKIN
$84.9M
$511K ﹤0.01%
30,262
-8,033
-21% -$133K
ZT
2523
DELISTED
Zimmer Energy Transition Acquisition Corp. Class A Common Stock
ZT
$511K ﹤0.01%
52,769
+1,888
+4% +$18.3K
CVM icon
2524
CEL-SCI Corp
CVM
$26M
$510K ﹤0.01%
4,327
+411
+10% +$66.9K
RADI
2525
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$509K ﹤0.01%
35,667
-114,450
-76% -$1.6M

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.